$FENC News

Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026

HC Wainwright & Co. Reiterates Buy on Fennec Pharmaceuticals, Maintains $16 Price Target

Fennec Pharmaceuticals (FENC) Stock Sees Fair Value Lift As Analysts Raise PEDMARK Views

Can Adherex Technologies (FENC) Climb 26.53% to Reach the Level Wall Street Analysts Expect?

B. Riley Securities Reiterates Buy on Fennec Pharmaceuticals, Raises Price Target to $18

Wedbush Maintains Outperform on Fennec Pharmaceuticals, Raises Price Target to $16

Fennec: The Turnaround Is Real, But The Stock Prices In Perfection (Downgrade)

Fennec Pharmaceuticals Inc (FENC) (Q2 2026) Earnings Call Highlights: Record Sales and ...

Adherex Technologies Q2 Earnings Call Highlights

Fennec Pharmaceuticals surges 8% as Q2 earnings and revenue beat estimates

Fennec Pharmaceuticals Inc. (FENC) Q2 2026 Earnings Call Transcript

Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Fennec Pharmaceuticals Q2 EPS $0.05 Beats $0.02 Estimate, Sales $17.874M Beat $16.095M Estimate

Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Fennec Announces Results of Annual Meeting

Fennec Announces New Research Supporting Pedmark's Use at ASCO Annual Meeting

HC Wainwright & Co. Maintains Buy on Fennec Pharmaceuticals, Raises Price Target to $16

Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting

Fennec Pharmaceuticals Inc (FENC) Q1 2026 Earnings Call Highlights: Record Sales Surge and ...